Turley James S 4

What Happened

• James S. Turley, a director of Precigen, Inc. (PGEN), had 71,839 restricted stock units (RSUs) vest on March 13, 2026 and those RSUs were converted into 71,839 shares of common stock. The filing also reports a simultaneous disposition of 71,839 shares at $0.00. No cash sale price or market sale is reported in the Form 4.

Key Details

• Transaction date: March 13, 2026 (reported on Form 4 filed March 16, 2026; appears to be filed in the normal timeframe).
• Transaction codes: M (exercise or conversion of a derivative security) for both the acquisition and the reported disposition.
• Shares acquired on conversion: 71,839 shares (no purchase price reported).
• Shares disposed: 71,839 shares at $0.00 (the filing does not state the reason for the $0.00 disposition).
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnotes: F1 — each RSU represents a contingent right to one share; F2 — RSUs vested in full on March 13, 2026.

Context

• This filing reflects RSU vesting and conversion to shares (an award/vesting event), not an open-market purchase or sale. The reported $0.00 disposition is noted in the filing but not explained; such entries are often related to withholding or transfers but the Form 4 here does not specify the cause. For investors, award vesting is routine compensation-related activity and does not by itself signal a buy or sell decision by the insider.